Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 88.0 | 1,542.7 | 30.0 | 53.8 | 11.6 |
| Revenue growth | -94.3% | 5042.2% | -44.2% | 365.4% | |
| Cost of goods sold | 46.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 41.6 | 1,542.7 | 30.0 | 53.8 | 11.6 |
| Gross margin | 47.3% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 1,213.0 | 984.7 | 840.4 | 426.0 | 267.1 |
| General and administrative | 899.9 | 402.4 | 654.6 | 66.4 | 25.4 |
| EBITA | -2,438.4 | 48.5 | -1,453.7 | -334.2 | -309.0 |
| EBITA margin | -2770.1% | 3.1% | -4845.6% | -621.4% | -2674.0% |
| Amortization of intangibles | 0.8 | 1.6 | | | |
| EBIT | -2,439.2 | 47.0 | -1,453.7 | -334.2 | -309.0 |
| EBIT margin | -2771.0% | 3.0% | -4845.6% | -621.4% | -2674.0% |
| Pre-tax income | -2,334.7 | 483.1 | -1,452.0 | -401.1 | -298.2 |
| Income taxes | 3.2 | -12.2 | 0.0 | -1.7 | 0.0 |
| Tax rate | | | 0.0% | 0.4% | 0.0% |
| Net income | -2,331.5 | 470.9 | -1,485.0 | -402.8 | -298.2 |
| Net margin | -2648.7% | 30.5% | -4950.0% | -749.0% | -2580.8% |
| |
| Diluted EPS | ($13.35) | $3.00 | ($201.19) | ($61.70) | ($51.93) |
| Shares outstanding (diluted) | 174.7 | 157.2 | 7.4 | 6.5 | 5.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|